Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Economic evidence in multiple sclerosis: a review

Gisela Kobelt¹

¹European Health Economics, Spéracèdes, France. gisela.kobelt@he-europe.com

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care

|March 9, 2005

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Burden among participants with central disorders of hypersomnolence in six European countries.

Sleep medicine·2026

Same author

Cost and Quality of Life of Disability Progression in Multiple Sclerosis Beyond EDSS: Impact of Cognition, Fatigue, and Limb Impairment.

PharmacoEconomics - open·2024

Same author

The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry.

Multiple sclerosis journal - experimental, translational and clinical·2023

Same author

Efficacy, safety and patient reported outcomes in patients with active relapsing multiple sclerosis treated with ocrelizumab: Final results from the PRO-MSACTIVE study.

Multiple sclerosis and related disorders·2022

Same author

Budget projections and clinical impact of an immuno-oncology class of treatments: Experience in four EU markets.

Journal of cancer policy·2022

Same author

Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study.

Neurology and therapy·2022